Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs.

Francesco Giuseppe FoschiAlberto BorghiAlberto GrassiArianna LanziElvira SperanzaTeo VignoliLucia NapoliDeanna OlivoniMichele SanzaEdoardo PolidoriGiovanni GrecoPaolo BassiFrancesco CristiniGiorgio BallardiniMattia AltiniFabio Continull On Behalf Of Mith Group

Published in: Journal of clinical medicine (2021)

Our embedded treatment model could be appropriate to increase the linkage to care of HCV-infected PWID. In this setting, DAA regimens are well tolerated and highly effective, achieving a lower rate of reinfection.

Keyphrases

hepatitis c virus infection
healthcare
palliative care
quality improvement
hepatitis c virus
pain management
affordable care act
human immunodeficiency virus
chronic pain
hiv testing